GlassScriptPhysician profile
Liping Shi
NPI 1861837379
$1,080.40
in general payments reported to CMS, 2019-2025
21 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $342 · 2023: $264 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.12 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.23 | 2022 | |
| Edwards Lifesciences Corporation | $135.97 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $124.90 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.77 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $77.29 | 2021-2022 | |
| Sanofi Pasteur INC. | $58.32 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.29 | 2021-2023 | Takhzyro |
| Genzyme Corporation | $47.54 | 2021-2022 | |
| Glaxosmithkline, LLC. | $47.42 | 2025 | Arexvy, Shingrix |
| Kowa Pharmaceuticals America, INC. | $40.84 | 2025 | Zoryve |
| Amarin Pharma, INC. | $37.56 | 2021 | |
| Verona Pharma, INC. | $30.02 | 2025 | Ohtuvayre |
| Abbvie INC. | $25.23 | 2023 | |
| Pfizer INC. | $23.59 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $23.13 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $21.80 | 2025 | Ozempic |
| Gilead Sciences, INC. | $21.30 | 2021 | |
| Exact Sciences Corporation | $18.18 | 2023 | Cologuard Collection Kit |
| Incyte Corporation | $17.78 | 2021 | |
| Leo Pharma INC. | $16.83 | 2023 | Adbry |
| Sobi, INC | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liping Shi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.